Clinical trial
Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected…
NCT00099658 · CIPRA SA, Other · Unknown status
Key facts
| NCT number | NCT00099658 |
|---|---|
| Title | Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children |
| Official title | Evaluation of Quantitative and Qualitative Antibody Responses to Streptococcus Pneumoniae and Haemophilus Influenzae Type b Conjugate Vaccines Amongst HIV-1-Exposed-Infected Children That Are Receiving Vs. Those Not Receiving Antiretroviral Therapy, as Well as Among HIV-1-Exposed-Uninfected Children… |
| Lead sponsor | CIPRA SA, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | HIV Infections, Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | Pneumococcal polysaccharide-protein conjugate vaccine |
| Enrollment | 579 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2013 |
| Completion | Jun 1, 2014 |
| First posted | Dec 20, 2004 |
| Last update posted | Feb 15, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: